UA43351C2 - Діюча речовина медичних та фармакологічних засобів з активністю антагоніста ексайторних амінокислот - Google Patents
Діюча речовина медичних та фармакологічних засобів з активністю антагоніста ексайторних амінокислотInfo
- Publication number
- UA43351C2 UA43351C2 UA96030972A UA96030972A UA43351C2 UA 43351 C2 UA43351 C2 UA 43351C2 UA 96030972 A UA96030972 A UA 96030972A UA 96030972 A UA96030972 A UA 96030972A UA 43351 C2 UA43351 C2 UA 43351C2
- Authority
- UA
- Ukraine
- Prior art keywords
- chocolate
- fat
- cocoa
- composition
- content
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 239000003194 amino acid receptor blocking agent Substances 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 239000002831 pharmacologic agent Substances 0.000 title 1
- 244000299461 Theobroma cacao Species 0.000 abstract 38
- 235000019219 chocolate Nutrition 0.000 abstract 30
- 239000003925 fat Substances 0.000 abstract 18
- 235000019197 fats Nutrition 0.000 abstract 18
- 239000000203 mixture Substances 0.000 abstract 13
- 238000000034 method Methods 0.000 abstract 9
- 235000009470 Theobroma cacao Nutrition 0.000 abstract 8
- 239000004615 ingredient Substances 0.000 abstract 8
- 238000004519 manufacturing process Methods 0.000 abstract 5
- 229940110456 cocoa butter Drugs 0.000 abstract 4
- 235000019868 cocoa butter Nutrition 0.000 abstract 4
- 235000003599 food sweetener Nutrition 0.000 abstract 4
- 239000003765 sweetening agent Substances 0.000 abstract 4
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 235000014633 carbohydrates Nutrition 0.000 abstract 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 235000013336 milk Nutrition 0.000 abstract 2
- 239000008267 milk Substances 0.000 abstract 2
- 210000004080 milk Anatomy 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 241000723382 Corylus Species 0.000 abstract 1
- 235000007466 Corylus avellana Nutrition 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010033307 Overweight Diseases 0.000 abstract 1
- 230000004888 barrier function Effects 0.000 abstract 1
- 235000014121 butter Nutrition 0.000 abstract 1
- 235000019879 cocoa butter substitute Nutrition 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 235000013861 fat-free Nutrition 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 235000004213 low-fat Nutrition 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 235000019629 palatability Nutrition 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000003825 pressing Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 235000019220 whole milk chocolate Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Confectionery (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4327516A DE4327516A1 (de) | 1993-08-17 | 1993-08-17 | Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin |
| PCT/EP1994/002649 WO1995005175A1 (en) | 1993-08-17 | 1994-08-10 | The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA43351C2 true UA43351C2 (uk) | 2001-12-17 |
Family
ID=6495312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA96030972A UA43351C2 (uk) | 1993-08-17 | 1994-10-08 | Діюча речовина медичних та фармакологічних засобів з активністю антагоніста ексайторних амінокислот |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5721258A (uk) |
| EP (1) | EP0716602B1 (uk) |
| JP (1) | JPH09501664A (uk) |
| KR (1) | KR100341952B1 (uk) |
| CN (1) | CN1086291C (uk) |
| AT (1) | ATE210442T1 (uk) |
| AU (1) | AU694447B2 (uk) |
| BG (1) | BG62430B1 (uk) |
| BR (1) | BR9407293A (uk) |
| CA (1) | CA2169718C (uk) |
| CZ (1) | CZ289040B6 (uk) |
| DE (2) | DE4327516A1 (uk) |
| DK (1) | DK0716602T3 (uk) |
| EE (1) | EE03204B1 (uk) |
| ES (1) | ES2168309T3 (uk) |
| HR (1) | HRP940464A2 (uk) |
| HU (1) | HU227765B1 (uk) |
| IL (1) | IL110681A (uk) |
| NO (1) | NO309842B1 (uk) |
| NZ (1) | NZ273292A (uk) |
| PT (1) | PT716602E (uk) |
| RU (1) | RU2166318C2 (uk) |
| SK (1) | SK283330B6 (uk) |
| UA (1) | UA43351C2 (uk) |
| WO (1) | WO1995005175A1 (uk) |
| YU (1) | YU49215B (uk) |
| ZA (1) | ZA946176B (uk) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19539861A1 (de) * | 1995-10-26 | 1997-04-30 | Asta Medica Ag | Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen |
| DE19541405A1 (de) * | 1995-11-07 | 1997-05-15 | Asta Medica Ag | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen |
| DE19625582A1 (de) * | 1996-06-27 | 1998-01-02 | Asta Medica Ag | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen |
| ATE284684T1 (de) | 1997-10-27 | 2005-01-15 | Sumitomo Pharma | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut |
| WO2001034172A2 (en) * | 1999-11-05 | 2001-05-17 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
| WO2001039760A2 (en) * | 1999-12-01 | 2001-06-07 | Duke University | Method of treating batten disease |
| US6821995B1 (en) | 1999-12-01 | 2004-11-23 | Duke University | Method of treating batten disease |
| DE10327674A1 (de) | 2003-06-20 | 2005-01-05 | Awd.Pharma Gmbh & Co. Kg | Injizierbare Darreichungsform von Flupirtin |
| DE10328260A1 (de) * | 2003-06-23 | 2005-01-27 | Schmidt, K.-G., Dr. med. | Flupirtine-Präparat |
| CA2550023C (en) * | 2003-12-16 | 2011-04-12 | Cnsbio Pty Ltd | Treatment of neuropathic pain |
| WO2006065204A1 (en) * | 2004-12-14 | 2006-06-22 | Astrazeneca Ab | Substituted aminopyridines and uses thereof |
| EP1688141A1 (en) | 2005-01-31 | 2006-08-09 | elbion AG | The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
| US20060258708A1 (en) * | 2005-05-16 | 2006-11-16 | Andrulis Peter J Jr | Method for treating Parkinson's disease and other neurological diseases |
| US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
| DE102011006425A1 (de) | 2010-03-31 | 2011-10-06 | Awd.Pharma Gmbh & Co. Kg | Pharmazeutische Zubereitung und deren Verwendung |
| DE102010030053A1 (de) | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
| MX2016001177A (es) * | 2013-07-31 | 2016-04-29 | Teva Pharma | Tratamiento de esclerosis multiple con la combinacion de laquinimod y flupirtina. |
| WO2019014547A1 (en) * | 2017-07-14 | 2019-01-17 | Texas Tech University System | FUNCTIONALIZED PYRIDINE CARBAMATES HAVING ENHANCED NEUROPROTECTOR ACTIVITY |
| DE102017007385A1 (de) | 2017-08-02 | 2019-02-07 | Christoph Hoock | Maleatfreie feste Arzneimittelformen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4481205A (en) * | 1980-09-13 | 1984-11-06 | Degussa Aktiengesellschaft | 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate |
| ATE25078T1 (de) * | 1982-10-27 | 1987-02-15 | Degussa | 2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung. |
| DE3337593A1 (de) * | 1982-10-27 | 1984-05-03 | Degussa Ag, 6000 Frankfurt | 2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung |
| NO860825L (no) * | 1985-03-23 | 1986-09-24 | Degussa | Fremgangsmaate til fremstilling av 2-amino-3-nitro-6-(4-fluor-benzylamino)-pyridin samt 2-amino-3-karbetoksyamino-6-(4-fluor-benzylamino)-pyridin. |
| IN172468B (uk) * | 1990-07-14 | 1993-08-14 | Asta Medica Ag |
-
1993
- 1993-08-17 DE DE4327516A patent/DE4327516A1/de not_active Ceased
-
1994
- 1994-08-10 EP EP94926828A patent/EP0716602B1/en not_active Expired - Lifetime
- 1994-08-10 DK DK94926828T patent/DK0716602T3/da active
- 1994-08-10 AT AT94926828T patent/ATE210442T1/de active
- 1994-08-10 CZ CZ1996465A patent/CZ289040B6/cs not_active IP Right Cessation
- 1994-08-10 CN CN94193106A patent/CN1086291C/zh not_active Expired - Lifetime
- 1994-08-10 JP JP7506731A patent/JPH09501664A/ja active Pending
- 1994-08-10 DE DE69429435T patent/DE69429435T2/de not_active Expired - Lifetime
- 1994-08-10 ES ES94926828T patent/ES2168309T3/es not_active Expired - Lifetime
- 1994-08-10 RU RU96105707/14A patent/RU2166318C2/ru active
- 1994-08-10 KR KR1019960700753A patent/KR100341952B1/ko active IP Right Grant
- 1994-08-10 HU HU9600355A patent/HU227765B1/hu unknown
- 1994-08-10 WO PCT/EP1994/002649 patent/WO1995005175A1/en active IP Right Grant
- 1994-08-10 SK SK214-96A patent/SK283330B6/sk not_active IP Right Cessation
- 1994-08-10 CA CA002169718A patent/CA2169718C/en not_active Expired - Lifetime
- 1994-08-10 NZ NZ273292A patent/NZ273292A/en not_active IP Right Cessation
- 1994-08-10 AU AU76528/94A patent/AU694447B2/en not_active Expired
- 1994-08-10 BR BR9407293A patent/BR9407293A/pt not_active Application Discontinuation
- 1994-08-10 US US08/602,742 patent/US5721258A/en not_active Expired - Lifetime
- 1994-08-10 PT PT94926828T patent/PT716602E/pt unknown
- 1994-08-15 YU YU51294A patent/YU49215B/sh unknown
- 1994-08-16 ZA ZA946176A patent/ZA946176B/xx unknown
- 1994-08-16 IL IL11068194A patent/IL110681A/xx not_active IP Right Cessation
- 1994-08-16 HR HRP4327516.8A patent/HRP940464A2/hr not_active Application Discontinuation
- 1994-10-08 UA UA96030972A patent/UA43351C2/uk unknown
- 1994-10-25 EE EE9400160A patent/EE03204B1/xx unknown
-
1996
- 1996-02-14 BG BG100356A patent/BG62430B1/bg unknown
- 1996-02-15 NO NO960607A patent/NO309842B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA43351C2 (uk) | Діюча речовина медичних та фармакологічних засобів з активністю антагоніста ексайторних амінокислот | |
| US8728553B2 (en) | Vitamin containing product | |
| RU2000125684A (ru) | Пищевые продукты, имеющие повышенное содержание полифенолов какао, и способы их производства | |
| JPH09502103A (ja) | フレーバリング組成物および方法 | |
| GR3018412T3 (en) | Milk chocolate and method of making the same | |
| EP1937078B1 (en) | High milk solid chocolate composition | |
| EP0930019A2 (en) | Composition for treating obesity and foods and drinks containing the same | |
| US6376002B1 (en) | Method for preparation of mulberry leaf powder and ice cream containing thereof | |
| EP0477935A1 (en) | Use of diglycerides in chocolate mixtures | |
| US3062655A (en) | Water insoluble defibrillated meat protein | |
| EP0553389A1 (en) | A cookie with a high cereal content | |
| JP4390376B2 (ja) | 水中油型乳化チョコレート類及びこれを用いた複合食品 | |
| US10045555B2 (en) | Shelf-stable spreadable cream | |
| JPH1198952A (ja) | 油脂含有食品及びその製造方法 | |
| JPH07322825A (ja) | 健康アイスクリーム及びその製造方法 | |
| JP2950191B2 (ja) | 油脂組成物及びそれを含む水中油型乳化物 | |
| EP0509509A1 (en) | Frozen dessert in which cocoa butter is used | |
| KR19980072453A (ko) | 상백피를 주성분으로 함유하는 당뇨환자용 과자류 조성물 | |
| JPH04158744A (ja) | チョコレート類の製造法 | |
| EP0589940B1 (en) | Monounsaturated dairy products | |
| RU2120777C1 (ru) | Майонез | |
| GB2280350A (en) | A method of producing soft candies | |
| RU2112389C1 (ru) | Способ повышения пищевой ценности продукта питания | |
| RU2121798C1 (ru) | Масса пралине для конфет и способ производства конфет из массы пралине | |
| RU2043731C1 (ru) | Белоксодержащее кондитерское изделие |